Martin Cross
Director/Board Member at Nhmrc National Institute of Dementia Research
Net worth: 14 661 $ as of 30/04/2024
Profile
Martin Cross currently works at Nhmrc National Institute of Dementia Research, as Non-Executive Director.
Dr. Cross also formerly worked at Generic Medicines Industry Association Pty Ltd., as Chairman from 2010 to 2013, Medicines Australia, as Chairman from 2013 to 2015, Anagenics Ltd., as Non-Executive Director from 2017 to 2023, OncoSil Medical Ltd., as Independent Non-Executive Director from 2017 to 2022, Alphapharm Pty Ltd., as Managing Director from 2010 to 2013, Novartis Australia Pty Ltd., as Managing Director & Head-Country from 2003 to 2008, Novartis New Zealand Ltd., as Managing Director & Head-Country from 2003 to 2008, and Novartis AG, as Head-Global Marketing from 2001 to 2003.
Dr. Cross received his undergraduate degree and doctorate degree from the University of Aberdeen.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ONCOSIL MEDICAL LTD
0.15% | 24/10/2022 | 4,510,965 ( 0.15% ) | 14 661 $ | 30/04/2024 |
Martin Cross active positions
Companies | Position | Start |
---|---|---|
Nhmrc National Institute of Dementia Research | Director/Board Member | - |
Former positions of Martin Cross
Companies | Position | End |
---|---|---|
ANAGENICS LIMITED | Director/Board Member | 27/11/2023 |
ONCOSIL MEDICAL LIMITED | Director/Board Member | 24/10/2022 |
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia. | Chairman | 01/01/2015 |
Alphapharm Pty Ltd.
Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Alphapharm has been developing and making generic medicines in Australia for more than 25 years. Millions of Australians take an Alphapharm generic medicine every day. In fact, It has become the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme and Australia's leader in generic medicines. Alphapharm medicines are available Australia-wide. Alphapharm medicines are made to the highest global quality standards and exported to more than 50 countries, including those in Europe and the US. Globally, Alphapharm is part of Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third-largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. | Chief Executive Officer | 01/10/2013 |
Generic Medicines Industry Association Pty Ltd.
Generic Medicines Industry Association Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Generic Medicines Industry Association Pty Ltd. operates as a representative body of generic and biosimilar medicine suppliers in Australia. The company was founded on February 23, 2001 and is headquartered in Deakin West, Australia. | Chairman | 01/01/2013 |
Training of Martin Cross
University of Aberdeen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ONCOSIL MEDICAL LIMITED | Health Technology |
ANAGENICS LIMITED | Consumer Non-Durables |
NOVARTIS AG | Health Technology |
Private companies | 6 |
---|---|
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia. | Health Technology |
Generic Medicines Industry Association Pty Ltd.
Generic Medicines Industry Association Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Generic Medicines Industry Association Pty Ltd. operates as a representative body of generic and biosimilar medicine suppliers in Australia. The company was founded on February 23, 2001 and is headquartered in Deakin West, Australia. | Commercial Services |
Alphapharm Pty Ltd.
Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Alphapharm has been developing and making generic medicines in Australia for more than 25 years. Millions of Australians take an Alphapharm generic medicine every day. In fact, It has become the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme and Australia's leader in generic medicines. Alphapharm medicines are available Australia-wide. Alphapharm medicines are made to the highest global quality standards and exported to more than 50 countries, including those in Europe and the US. Globally, Alphapharm is part of Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third-largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. | Health Technology |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Health Technology |
Novartis New Zealand Ltd.
Novartis New Zealand Ltd. Medical DistributorsDistribution Services Novartis New Zealand Ltd. engages in the import, marketing and wholesale of pharmaceutical and animal health products. The company is headquartered in Auckland, New Zealand. | Distribution Services |
Nhmrc National Institute of Dementia Research |
- Stock Market
- Insiders
- Martin Cross